Cassava Sciences Inc (USD)
SAVA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range1.83 | 2.05
52-Wk Range0.76 | 2.55
Last Close1.88
Mkt Cap (m)32.37
Dividend yield-
ISINUS14817C1071
Volume1,308,554
Exchange VenueNAS

Company Profile

Pain Therapeutics Inc is a biopharmaceutical company that develops novel drugs. The Company has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma.

Key Information
Price/Earning-
Price/Book1.86
Price/Sales-
P/CF-
Rev Growth (3 year avg)0.00
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-44.72
Debt/Equity-

Legal Documents

Prospectus
en 17/08/2018
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)41
Operating Income (m)31-12-14-15-12-7
Net Income (m)32-12-14-15-12-7
Basic EPS4.90-1.89-2.17-2.31-1.82-0.61
Avg. Diluted Shares Outstanding (m)6677711
Balance Sheet
USD201320142015201620172018
Current Assets (m)504132191120
Non Current Assets (m)
Total Assets (m)504132191120
Current Liabilities (m)213111
Total Liabilities (m)------
Total Equity (m)484029191020
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-7-10-9-12-8-5
Capital Expenditure (m)---
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
1.88
Last Price